ANALISIS BIAYA MINIMAL CANDESARTAN DIBANDINGKAN AMLODIPIN PADA PASIEN HIPERTENSI RAWAT JALAN DI RS “X” KOTA SAMARINDA

Abstract

Hypertension is a condition in which there is an increase in blood pressure in the arteries above 140/90 mmHg in adults with at least three consecutive measurements. Hypertension is one of the degenerative diseases that require long treatment for life. The use of long-term drugs for hypertensive patients certainly has an impact on the high cost of treatment. The purpose of this study was to find out the more minimal cost between the use of candesartan and amlodipine in outpatient hypertension patients in Hospital "X" samarinda city in 2020 using cost minimization analysis method based on the hospital perspective. This study is an epidemiological survey with a descriptive design, data taken retrospectively through the search of secondary data, namely patient medical hospitals, details of drug costs in the pharmaceutical section, and hospital information systems. Components of the costs collected include antihypertensive costs, other drug costs, administrative costs, specialist examination service fees, and polyclinic service fees. Data was collected from July to December 2020. The subjects of the study were outpatient hypertension patients at Hospital "X" in Samarinda city who received candesartan or amlodipin therapy. Sampling with purposive sampling technique and samples obtained is 90 patients. The cost measured is the direct medical cost of outpatient hypertension patients. The data was analyzed by identifying an overview of antihypertensive use, total direct medical costs and cost minimization analysis. The results showed that of the 90 patients there were 35 patients (38.89%) were men and 55 patients (61.11%) were women. Patients with hypertension are in the age range of 30 to 59 years, which is as many as 50 patients. The most widely used antihypertensive drug was amlodipine (62 patients) compared to candesartan (28 patients). The results of the analysis of CMA (Cost Minimization Analysis) methods for candesartan drugs have an average total cost of IDR. 221,940 and amlodipine drugs amounting to IDR. 190,008.61, so it can be concluded that the antihypertensive that has the minimum cost is amlodipine, with an average total cost smaller than candesartan.